Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Payables (2018 - 2026)

TELA Bio has reported Payables over the past 8 years, most recently at $2.3 million for Q4 2025.

  • For Q4 2025, Payables rose 7.55% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $2.3 million, up 7.55%, while the annual FY2025 figure was $2.3 million, 7.55% up from the prior year.
  • Payables for Q4 2025 was $2.3 million at TELA Bio, down from $2.4 million in the prior quarter.
  • Over five years, Payables peaked at $5.7 million in Q1 2022 and troughed at $965000.0 in Q1 2021.
  • A 5-year average of $2.7 million and a median of $2.3 million in 2021 define the central range for Payables.
  • On a YoY basis, Payables climbed as much as 490.98% in 2022 and fell as far as 36.45% in 2022.
  • Year by year, Payables stood at $2.4 million in 2021, then tumbled by 36.45% to $1.5 million in 2022, then grew by 8.67% to $1.7 million in 2023, then increased by 28.79% to $2.1 million in 2024, then grew by 7.55% to $2.3 million in 2025.
  • Business Quant data shows Payables for TELA at $2.3 million in Q4 2025, $2.4 million in Q3 2025, and $1.7 million in Q2 2025.